Clinical trial
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for…
NCT00370370 · Shahid Beheshti University of Medical Sciences, Other · Unknown status
Key facts
| NCT number | NCT00370370 |
|---|---|
| Title | Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neovascular Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | bevacizumab, bevacizumab + triamcinolone acetonide |
| Start date | Nov 1, 2005 |
| First posted | Aug 31, 2006 |
| Last update posted | Jun 26, 2008 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: